Taskin, E. Et Al. 2020. Silencing HMGB1 expression inhibits adriamycin's heart toxicity via TLR4 dependent manner through MAPK signal transduction. JOURNAL OF BUON , vol.25, no.1 , 554-565.

Taskin, E., Guven, C., Kaya, S. T., Sariman, M., EMRENCE, Z., Ekmekci, S. S., ... ABACI, N.(2020). Silencing HMGB1 expression inhibits adriamycin's heart toxicity via TLR4 dependent manner through MAPK signal transduction. JOURNAL OF BUON , vol.25, no.1, 554-565.

Taskin, Eylem Et Al. "Silencing HMGB1 expression inhibits adriamycin's heart toxicity via TLR4 dependent manner through MAPK signal transduction," JOURNAL OF BUON , vol.25, no.1, 554-565, 2020

Taskin, Eylem Et Al. "Silencing HMGB1 expression inhibits adriamycin's heart toxicity via TLR4 dependent manner through MAPK signal transduction." JOURNAL OF BUON , vol.25, no.1, pp.554-565, 2020

Taskin, E. Et Al. (2020) . "Silencing HMGB1 expression inhibits adriamycin's heart toxicity via TLR4 dependent manner through MAPK signal transduction." JOURNAL OF BUON , vol.25, no.1, pp.554-565.

@article{article, author={Eylem Taskin Et Al. }, title={Silencing HMGB1 expression inhibits adriamycin's heart toxicity via TLR4 dependent manner through MAPK signal transduction}, journal={JOURNAL OF BUON}, year=2020, pages={554-565} }